Health, Industry
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
|
Policies or Program
|
Health, Industry
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
|
Policies or Program
|
Budget, Health, Industry
|
Engagement with officials regarding Health Canada’s National Rare Disease Drug Strategy, and other aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary
|
Policies or Program
|
Health, Industry
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program, Regulation
|